Setting the tone for the biopharma industry as it enters a new year, the J.P. Morgan Healthcare Conference (JPM) held each January has once again led to reflections, projections and earnest hopes for improving financial and M&A markets. Despite concerns over valuations, raising money and pricing issues, industry leaders are generally upbeat as the industry moves into 2024. JPM’s Sophie Jones, managing director of health care investment banking, noted in a Jan. 18 webinar sponsored by the Biotechnology Innovation Organization that the conference included more than 700 companies. “It’s morphing now into really the kickoff into everybody’s year.”
Getchell Gold Corp. is pleased to announce that the Company has delivered the final US$1.6 million earn-in option cash payment and US$1 million share issuance to acquire a 100% interest in the Fondaway Canyon and Dixie Comstock gold properties. - Veroeffentlicht am 03.01.2024
, 27, 2023 - Canstar Resources Inc. & , is pleased to announce its intention to complete non-brokered private placement financings for total gross proceeds of up to $735,000, consisting of up to 10,000,000 hard dollar units of the Company at a price. - Veroeffentlicht am 27.12.2023